Gestational trophoblastic neoplasia: where we came from, where we stand today, where we are heading. Keynote address.
Goldstein
Donald P
DP
New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. dgoldstein@partners.org
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D031901:Gestational Trophoblastic Disease / Q000188:drug therapy / Q000266:history* / Q000473:pathology; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D009367:Neoplasm Staging; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000266:history* / Q000473:pathology
D000970:Antineoplastic Agents